Su‐Jin Koh

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial

Yeon Hee Park, Tae‐Yong Kim, Gun Min Kim et al. · The Lancet Oncology · 2019 · 120 citations

Breast Oncology, Medicine, Pharmacology +8

Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death

Sook‐Kyoung Heo, Eui‐Kyu Noh, Jeong Yi Kim et al. · Scientific Reports · 2017 · 67 citations · Full text

Hematological Malignancy, Tumor Biology, Chronic Myeloid Leukemia +13

Validation of the Edmonton Symptom Assessment System in Korean Patients With Cancer

Jung Hye Kwon, Seung-Hyun Nam, Su‐Jin Koh et al. · Journal of Pain and Symptom Management · 2013 · 61 citations · Full text

Medicine, Cancer Management, Diagnosis +6

Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation

Jaekyung Cheon, Yoo Jin Lee, Jae‐Cheol Jo et al. · Supportive Care in Cancer · 2020 · 38 citations

Quality Of Life, Life Assessment, Transplantation +10

Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea

Jae‐Cheol Jo, Jin Ho Baek, Su‐Jin Koh et al. · Asia-Pacific Journal of Clinical Oncology · 2015 · 32 citations